Thorell Marella
Chief Financial Officer at Evelo Biosciences, Inc.
- Sold, on record
- $26k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 8, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Evelo Biosciences, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Evelo Biosciences, Inc.RoutineMay 8 2023
Sold 38,531 shares at $0.13 ($5k)
Thorell Marella, Chief Financial Officer
10b5-1 planSold 29.6% of holdings ($17k position)91,469 shares leftFirst sale on recordFiling
- 2 Form 4 sale Evelo Biosciences, Inc.RoutineAug 8 +92 days
Sold 2,004 shares at $9.51 ($19k)
Thorell Marella, Chief Financial Officer
10b5-1 planSold 18.1% of holdings ($105k position)9,069 shares leftFiling
- 3 Form 4 sale Evelo Biosciences, Inc.RoutineNov 2 +86 days
Sold 3,999 shares at $0.33 ($1k)
Thorell Marella, Chief Financial Officer
10b5-1 planSold 18.5% of holdings ($7k position)17,570 shares leftFiling
- 4 Form 4 sale Evelo Biosciences, Inc.RoutineNov 8 +6 days
Sold 1,811 shares at $0.33 ($598)
Thorell Marella, Chief Financial Officer
10b5-1 planSold 7.5% of holdings ($8k position)22,259 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | Evelo Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 1,811 | $598 | 7.5% | Routine | SEC |
| Nov 2, 2023 | Evelo Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 3,999 | $1k | 18.5% | Routine | SEC |
| Aug 8, 2023 | Evelo Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 2,004 | $19k | 18.1% | Routine | SEC |
| May 8, 2023 | Evelo Biosciences, Inc. | Chief Financial Officer | Form 4 sale | 38,531 | $5k | 29.6% | Routine | SEC |